PHA Classroom banner

>> Back to Recordings

Session Recording from PHA's 2010 9th International PH Conference

Medicare Prescription Drug Coverage & Finding Help with Insurance Co-Payments

June 26, 2010 

Medical therapies for PAH are expensive. This session will provide an overview of Medicare, Medicaid and commercial insurance coverage for PAH medications. Panelists will provide information on the prior authorization process and describe funding programs that assist patients with medication co-payments.

Session handout (PDF)

View Session Recording
(recording will open in a new window)

Presenter Information

Miranda James, JD, Caring Voice Coalition, Mechanicsville, Va. (Chair)
Jeremy Feldman, MD, Arizona Pulmonary Specialists, Phoenix, Ariz.
Doyle Hull, Caring Voice Coalition, Mechanicsville, Va.






Actelion Pharmaceuticals US, Inc. Gilead Sciences, Inc. United Therapeutics Corporation Bayer HealthCare
This is a program of the PHA Medical Education Fund, made possible through unrestricted educational grants from our supporters.


FacebookGoogle +TwitterLinkedInPinterestInstagramYouTubeBloggerFeedsPHAware Download our App

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
    Privacy Policy    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2015 Pulmonary Hypertension Association. All Rights Reserved.


The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.